Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases Research (Rce)

The summary for the Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases Research (Rce) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases Research (Rce): The National Institute of Allergy and Infectious Diseases (NIAID) invites applications (U54) for funds to develop Regional Centers of Excellence (RCE) in areas related to Biodefense and Emerging Infectious Diseases Research (see page 9 for regions). The NIAID will also be releasing another RFA for P- RCE Planning Grants (U56) soon. This program will provide funds for start up and developmental activities that will lead to RCE applications. The overall goal of the RCE Program is to develop and maintain strong infrastructure and multifaceted research and development activities that will provide the scientific information and translational research capacity to make the next generation of therapeutics, vaccines and diagnostics against the CDC Category A-C Agents (http://www.bt.cdc.gov/agent/agentlist.asp#catagoryadiseases), with particular emphasis on Category A. To accomplish this goal, the Centers will be provided with support 1) to develop and conduct programs of investigator-directed research; 2) to train researchers and other personnel for biodefense research activities; 3) to develop and maintain comprehensive core facilities to support the research and training activities of the RCE; 4) to develop translational research capacity for testing and validating vaccine, therapeutic and diagnostic concepts for biodefense and emerging infectious diseases; 5) to maintain and make available core facilities and other support to approved investigators from academia, biotech companies, the pharmaceutical industry, and other appropriate entities in the region for the purpose of performing basic research and for testing and evaluating vaccines, therapeutics and diagnostics for CDC Category A-C Agents; 6) to be ready and available to provide facilities and scientific support to first-line responders in the event of a national biodefense emergency. This Request For Applications (RFA) invites research institutions and groups of investigators to form consortia and develop applications for programs to address the fundamental research and development questions that will provide the information needed to counter the threat of bio-terrorism. Diverse research and development approaches are encouraged, as long as they include the following essential features: a biodefense research focus on CDC Category A-C Agents, particularly Category A, which incorporates a translational component with the long term goal of developing testable products. Additionally, the consortium must document: institutional commitment, organizational capabilities, ability to develop and expand facilities, plans for training of new investigators and other participants in the national biodefense effort, and interdisciplinary coordination and collaboration, particularly linkages to federal, state, and local agencies. The consortium must have a lead team of individuals responsible for the overall management and direction of the RCE. A group of Center member researchers, with expertise in Biodefense and emerging infectious diseases research, is required to lead the research thrust which underlies all the other activities of the RCE. In addition, the RCE should designate specific platforms and technologies that will serve as the basis for the Center's development programs. Platforms are cross-cutting technologies or experimental approaches that integrate the research and development activities. Examples of platforms include: genomics, proteomics, animal models, pre-clinical development, but others are welcome. The overall direction and scope of activities of the RCE Program and its participant Center sites will be centrally coordinated and monitored by a Management and Oversight Committee that is run through the RCE Program Office at NIAID to ensure that the RCE program contributes maximally and effectively to the biodefense and emerging infectious diseases effort. PUBLIC BRIEFING DATE: August 8, 2002 An informational session for investigators representing groups planning to submit applications in response to this RFA will be held August 8, 2002 at the Marriott Washingtonian Center Hotel in Gaithersburg, MD. Representatives from the NIAID extramural research programs and Division of Extramural Activities will be available to provide information and to answer questions relevant to preparing applications in response to this RFA. Questions and Answers from discussions at the meeting will be available on the NIAID website for those unable to attend.
Federal Grant Title: Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases Research (Rce)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-AI-02-031
Type of Funding: Grant
CFDA Numbers: Information not provided
CFDA Descriptions: Information not provided
Current Application Deadline: No deadline provided
Original Application Deadline: Jan 15, 2003
Posted Date: Sep 04, 2002
Creation Date: Feb 14, 2003
Archive Date: Feb 14, 2003
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Individuals For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com